The rise of fentanyl and other synthetic opioids is unlike any drug crisis in U.S. history. Limiting policy responses to existing approaches will likely be insufficient and may condemn many people to early deaths.
We engaged experts using an online modified Delphi approach to develop consensus on the appropriateness of strategies for managing cancer pain in individuals with co-occurring advanced cancer and opioid use disorder.
The volume of prescription opioids dispensed from retail pharmacies declined by 21 percent from 2008 to 2018, but the decline was not uniform across geographic areas, among types of patients, or by type of prescriber.
Researchers conducted an extensive simulation study to compare the statistical performance of commonly used methods for evaluating state-level opioid policies, including popular difference-in-differences methods.
The new “traffic light” coalition in Germany recently agreed to regulate the sale of cannabis to adults for recreational purposes in licensed shops. International experience has shown that great care is needed in how cannabis policy is shaped.
Researchers summarize the multitude of ways access to and utilization of treatment for individuals with OUD might have been expanded by state and federal policy during COVID-19 pandemic in 4 key areas: telehealth, privacy, licensing, and medication.
The cover story highlights how RAND is helping to redefine high-quality care for service members with a TBI or PTSD. The Q&A with two Marines who work at RAND sheds light on how their military service informs their research and analysis.
Army recruits with a history of marijuana use can ask for a waiver like those who have diabetes or insomnia. They are just as likely as others to complete their first term and make sergeant, and are less likely to leave the Army for health or performance reasons.
Some communities hard hit by the opioid crisis are interested in opening supervised consumption sites—places where people who use drugs can do so under supervision of trained staff. What could be done to make it easier to pilot and evaluate these sites in the United States?
This cross-sectional study of substance use disorder treatment facilities examined the national share of facilities that offer medication treatment for opioid use disorder (MOUD) and population-based measures of geographic accessibility of facilities offering MOUD.
This study used a decade of data from U.S. counties to examine how rates of neonatal opioid withdrawal syndrome (NOWS) and county-level characteristics were associated with entry in the child welfare system.
We reviewed medical literature for recent studies that use claims data to construct opioid utilization measures, then developed a guide for researchers regarding opioid utilization measures and measure definitions, and how these may influence study results.